Calley Means, a MAHA leader who just resigned from the Trump administration, says Americans "are being duped and gaslighted ...

The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal ...

Democrats are likely to focus on reversing Medicaid cuts and expanding insurance coverage, giving a boost to health care ...

For AI to achieve its full potential in women’s health, medical records need to tell the complete story,” experts write.

Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular ...

Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?

People with cognitively unimpaired Alzheimer’s “may be asymptomatic, but they do have a disease experience,” writes Jason ...

Two newly elected lawmakers with science backgrounds hope to push back against Trump administration cuts to health equity programs.

New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.

Katherine MacPhail is a reporter and editorial events programmer for STAT. CHICAGO — What if the key to getting cancer immunotherapy to parts of the world that can’t access it is lowering the dose? A ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Voters in 2026 midterm elections decided state health policy ballot measures on abortion rights, marijuana laws, science ...